摘要
目的探讨帕多瓦(PADUA)评分是否能预测腹腔镜肾肿瘤射频消融术(LRFA)并发症发生的风险,根据LRFA本身的特点,改良PADUA评分系统,使其能够更好地预测LRFA的手术风险。方法回顾性分析160例单病灶肾肿瘤腹腔镜射频消融患者的临床资料,根据其术前CT进行标准的PADUA评分和改良PADUA评分(m-PADUA),分析这两种评分与手术并发症的相关性。结果标准的PADUA评分与LRFA并发症风险无明显相关性(P=0.307),而改良的PADUA评分与之有明显相关性(P=0.016)。结论标准的PADUA评分不适用于LRFA风险的预测,而改良评分能较好地预测LRFA手术风险。
Objective To investigate whether the standard PADUA Nephrometry Score can predict complications after laparoscopic radiofrequency ablation(LRFA),and to explore whether the modified PADUA score system(m-PADUA)is able to predict the risks.Methods Clinical data of 160 cases undergone single lesion LRFA were retrospectively analyzed.The preoperative CTResults were evaluated with the 2 systems,and then the correlation between the two scores and surgical complications were assessed.Results The standard PADUA Nephrometry Score had no obvious correlation with risk of complications(P=0.307),but the modified PADUA score had a significant correlation(P=0.016).Conclusions LRFA is a safe and effective treatment.The standard PADUA Nephrometry Score does not apply to LRFA risk prediction,while our modified score system can better predict LRFA operation risks.
出处
《现代泌尿外科杂志》
CAS
2015年第7期460-463,共4页
Journal of Modern Urology
关键词
肾癌
腹腔镜射频消融术
PADUA评分
改良
并发症
renal carcinoma
laparoscopic radiofrequency ablation
PADUA Nephrometry Score
modify
surgical com-plication